Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline

Prostate Cancer Drug Linked to Lower Risk of Cognitive Decline
ShareXFacebook

(MedPage Today) -- CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in cognitive function compared with those who received darolutamide (Nubeqa), according to results from...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Migraine With Aura Tied to Higher Stroke Risk
MedPage Today

Migraine With Aura Tied to Higher Stroke Risk

(MedPage Today) -- Middle-aged and older adults who had migraine with aura had a greater risk of subsequent stroke, a study of 11,000 people showed. Over 6 years, migraine with aura was associated with a 73% higher risk of ischemic stroke compared...

Read more →
Advertisement